Gencurix Inc.

Company Profile

Sector

Healthcare

Industry

Diagnostics & Research

Employees

N/A

Website

www.gencurix.com

Country

South Korea

Exchange

KOSDAQ

Founded 2011Seoul, South Korea

Gencurix provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer. Its portfolio also includes Droplex, a genetic test based on digital PCR platform, eDX, an early diagnosis for cancer with liquid biopsy, GenePro SARS-CoV-2 Test kit, GenoCTC, a circulating tumor cell isolator, and GenePro LAMP Cycler, a portable device for infectious disease detection.

The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. Founded in 2011, the company is headquartered in Seoul, South Korea.

Key Stats

52-Week Range

₩1321.00₩7320.00

Beta1.65

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.